Delivery Order SPE2DB22D3401-SPE2DB25FT0HV

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, and has a ceiling value of $10,866.06. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It has an ultimate completion date of June 11, 2024. The contract does not...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,652.47 and a ceiling value of $2,652.47. The ultimate completion date is February 6, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to procure Prolia 60 mg/ml syringes. The contract has a ceiling value of $12,857.40 and an ultimate completion date of March 12, 2025. This contract award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,428.70, is a delivery order for the drug Prolia 60 mg/ml syringe. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price arrangement. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,431.48 and an ultimate completion date of December 12, 2022. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract, with a ceiling value of $49,197.21, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,743.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Prolia 60 mg/mL syringes. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order worth $8,048.74, with an ultimate completion date of February 27, 2024. The contract was awarded on February 26, 2024 and does not have a...
This contract award to Amerisourcebergen Drug Corp involves the delivery of Prolia 60 mg/mL syringes to the Defense Logistics Agency (DLA). It is a firm fixed-price delivery order with a ceiling value of $4,068.63 and a period of performance ending on August 14, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical to provide a wide range of...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT0HV
    Delivery Order

This contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $8,209.35 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order with a firm fixed price and has an ultimate completion date of October 25, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 1/23/25, 9:16 AM